Table 1

Demographic data of study groups

Control

Drug-med pts

Drug-free

Drug-naïve

(N=31)

(N=44)

pts(N=28)

pts(N=15)

p-value**


Age*

33.9 ± 9.5

37.3 ± 11.4

35.1 ± 9.1

30.8 ± 7.7

NS***

Sex

Male

17

33

6

16

NS***

Female

14

11

9

15

Age of symptom onset*

22.5 ± 6.8

26.7 ± 9.2

28.1 ± 7.8

NS***

Duration of illness*

12.7 ± 8.3

7.6 ± 5.2

2.5 ± 3.0

<0.01

TBPRS

36.1 ± 12.9

41.9 ± 25.4

36.9 ± 18.2

NS***

Dose of antipsychotics****

1000.1 ± 130.4

769.6 ± 491.2

614.2 ± 234.7

NS***

Duration of no-medication

10.61 ± 7.01

(mean months ± SD)


* :mean ± standard deviation (years) ** :one-way ANOVA test, independent T-test, Chi-square test *** :NS; statistically non-significant **** :chlorpromazine equivalent dose (mg/cay)

Kwak et al. BMC Medical Genetics 2001 2:3   doi:10.1186/1471-2350-2-3

Open Data